|
|
Ulcerative Colitis and the Role of S1P Receptor Modulators and JAK Inhibitors " A Wheel of Knowledge Challenge!
Ulcerative colitis (UC), a type of inflammatory bowel disease, is a chronic relapsing condition characterized by an overly active immune response in the large intestine, resulting in inflammation and ulceration. Given the increasing prevalence of disease and rapid influx of available biologics and small molecule therapies, there is great need for ongoing education regarding new and emerging treatment approaches for the management of UC. In this continuing education program, expert clinicians w... |
|
|
Making the Case to Use JAK Inhibitors for Rheumatoid Arthritis"Who, What, When, and How
Target Audience
This activity has been designed to address the educational needs of rheumatology clinicians. It may also benefit other clinicians involved in the management of patients with rheumatoid arthritis (RA).
Program Overview
Join Dr Rigby and Dr Troum as they discuss the use of Janus kinase (JAK) inhibitors for the treatment of RA. In this program they will discuss the latest post-hoc analysis of the ORAL Surveillance trial, which shows which patients can safely and effectively u... |
|
|
Recognizing the Substantial Burden of Alopecia in Pediatric Patients and Building Multidisciplinary Capacity and Competence to Address Unmet Needs
Hair loss can have a profound psychological impact, especially on adolescents who may face social stigma or have self-esteem issues. Accurate diagnosis and appropriate management in this patient population can improve not only physical symptoms but also mental well-being.
If you’re a clinician who treats alopecia areata (AA) in pediatric patients, take your skills to the next level by accessing ACHL’s AdaptED® platform, which offers a tailored learning experience for busy clinicians, ... |
|